By Debdeep Gupta | 15 Sep, 2025
Alembic Pharma shares gain on EIR from USFDA for Panelav unit
Alembic Pharmaceuticals share price rose in the opening trade on September 15 following the company received establishment inspection report (EIR) post inspection by the US Food and Drug Administration (USFDA).At 09:20am, Alembic Pharmaceuticals was quoting at Rs 953.90, up Rs 8.10, or 0.86 percent, on the BSE.".... has EIR today for the inspection carried out conducted from 26th May, 2025 to 31st...
Live Comments
Telegram_DreamNifty 2023-05-25 18:42:56
dont buy until and unless it crosses 100 ... only promoters and relatives manage the stock Price ..no mutual fund house interest in buying this cramp..
Login & Reply Like(0) Dislike(0) Repost Spamparvin 2022-08-19 19:41:15
sure shot 250 by December 2022 - dont sell a single share.
Login & Reply Like(0) Dislike(0) Repost Spam